(Q44137053)

30 November 2017

Variation at the APOE -491 promoter locus is associated with altered brain levels of apolipoprotein E. (English)

1 reference

30 November 2017

1

1 reference

30 November 2017

5

1 reference

30 November 2017

Hone E

2

1 reference

30 November 2017

Taddei K

3

1 reference

30 November 2017

Harper C

4

1 reference

30 November 2017

McClean C

6

1 reference

30 November 2017

Masters C

7

1 reference

30 November 2017

Lautenschlager N

8

1 reference

30 November 2017

Gandy SE

9

1 reference

30 November 2017

Martins RN

10

1 reference

30 November 2017

language of work or name

English

0 references

publication date

1 January 2002

1 reference

30 November 2017

1 reference

30 November 2017

7

1 reference

30 November 2017

886-890

1 reference

30 November 2017

8

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.mp.4001097

30 November 2017

0 references

cites work

Apolipoprotein E: cholesterol transport protein with expanding role in cell biology

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001097

Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001097

Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001097

Increased plasma apolipoprotein E (apoE) levels in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001097

Allelic polymorphisms in the transcriptional regulatory region of apolipoprotein E gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001097

A polymorphism in the regulatory region of APOE associated with risk for Alzheimer's dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001097

Pronounced impact of Th1/E47cs mutation compared with -491 AT mutation on neural APOE gene expression and risk of developing Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001097

A new polymorphism in the APOE promoter associated with risk of developing Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001097

Effect of APOE genotype and promoter polymorphism on risk of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001097

Apolipoprotein E mRNA in the brains of patients with Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001097

High expression of apolipoprotein E mRNA in the brains with sporadic Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001097

Increased apolipoprotein E mRNA in the hippocampus in Alzheimer disease and in rats after entorhinal cortex lesioning

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001097

Apolipoprotein E (apoE) levels in brains from Alzheimer disease patients and controls.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001097

Lack of apolipoprotein E dramatically reduces amyloid beta-peptide deposition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001097

Apolipoprotein E is essential for amyloid deposition in the APP(V717F) transgenic mouse model of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001097

Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001097

Effect of the APOE promoter polymorphisms on cerebral amyloid peptide deposition in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001097

Astrocytes synthesize apolipoprotein E and metabolize apolipoprotein E-containing lipoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001097

7 January 2021

The -491AA polymorphism in the APOE gene is associated with increased plasma apoE levels in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001097

7 January 2021

Apolipoprotein E genotyping by one-stage PCR

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001097

7 January 2021

Neuropathological changes in scrapie and Alzheimer's disease are associated with increased expression of apolipoprotein E and cathepsin D in astrocytes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001097

7 January 2021

Identifiers

DOI

10.1038/SJ.MP.4001097

1 reference

30 November 2017

1 reference